Avicanna Inc. (AVCNF)
OTCMKTS · Delayed Price · Currency is USD
0.1825
-0.0030 (-1.62%)
Sep 17, 2025, 12:02 PM EDT
Avicanna Market Cap
Avicanna has a market cap or net worth of $21.41 million as of September 17, 2025. Its market cap has decreased by -30.89% in one year.
Market Cap
21.41M
Enterprise Value
27.32M
Revenue
18.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.18
Market Cap Chart
Since July 18, 2019, Avicanna's market cap has decreased from 104.82M to 21.41M, a decrease of -79.58%. That is a compound annual growth rate of -22.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 21.41M | -8.36% |
| Dec 31, 2024 | 23.36M | -2.78% |
| Dec 29, 2023 | 24.03M | 5.84% |
| Dec 30, 2022 | 22.71M | -19.71% |
| Dec 31, 2021 | 28.28M | -26.61% |
| Dec 31, 2020 | 38.54M | -11.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |